The significant association between the p16INK4a variant rs3814960 and molecular subgroups of patients with colon cancer is intriguing and deserves to be analyzed in a larger group of patients and controls to establish the normal distribution of the genotypes and any possible impact on colon cancer risk and patient outcome. This evidence concerns the gene CDKN2A and malignant colon neoplasm.